Phase III, multicentre, randomised study of fludarabine/cyclophosphamide combination with or without Rituximab in patients with untreated mantle cell lymphoma

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate the overall survival of patients treated with cyclophoshamide and fludarabine in comparison to rituximab, cyclophosphamide and fludarabine.

Critère d'inclusion

Mantle cell lymphoma

Liens

euctr
ictrp